Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Apollo Hospitals Q4...

    Apollo Hospitals Q4 revenue, Net Profit up, EBITDA crosses Rs 1000 crore milestone

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-06-01T14:36:08+05:30  |  Updated On 1 Jun 2019 2:36 PM IST
    Apollo Hospitals Q4 revenue, Net Profit up, EBITDA crosses Rs 1000 crore milestone

    Apollo Hospitals has delivered a strong performance in the final quarter of the year, with the continued growth of volumes, revenues and margins. There was a good performance, both in the hospitals and in the pharmacy division, the company said.


    New Delhi: Healthcare major Apollo Hospitals Enterprise Thursday reported a 28.57 per cent rise in standalone net profit to Rs 76.68 crore for the fourth quarter ended March 31, on account of strong performance across verticals.


    The company had posted a net profit of Rs 59.64 crore in the same period of 2017-18, Apollo Hospitals Enterprise said in a BSE filing.


    Standalone revenue from operations stood at Rs 2,167.11 crore for the quarter under consideration. It was Rs 1,863.42 crore for the same period a year ago.


    The company said its earnings before interest, tax, depreciation and amortisation (EBITDA) in FY19 crossed landmark of Rs 1,000 crore for the first time.


    Read Also: Apollo Hospitals Q3 profit rises 29 percent to Rs 86 crore on higher revenues

    Apollo Hospitals has delivered a strong performance in the final quarter of the year, with the continued growth of volumes, revenues and margins. There was a good performance, both in the hospitals and in the pharmacy division, the company said.


    For the 2018-19 fiscal, the net profit of the company rose to Rs 302.76 crore as against Rs 233.20 crore in the preceding fiscal.


    The company's revenue from operations in 2018-19 stood at Rs 8,336.66 crore. It was Rs 7,183.01 crore for 2017-18.


    "I am pleased that we have consolidated our position as India's largest private healthcare provider in FY18-19, with our numbers signalling robust growth across multiple verticals," Apollo Hospitals Chairman Prathap C Reddy said.


    Standalone revenues of the healthcare services division grew 14 per cent to Rs 4,450.6 crore in FY19 compared to Rs 3,914.1 crore in FY18, Apollo Hospitals said.


    "We added 490 stores and closed 83 stores for a net addition of 407 stores in FY19. The total store network as of March 31, 2019, stands at 3,428 operational stores," it added.


    Revenues grew by 19 per cent to Rs 3,886 crore in FY19 from Rs 3,268.9 crore in FY18.


    The company's board has recommended a dividend of Rs 6 per share (120 per cent of the face value of Rs 5 each) for the financial year ended March 31, 2019, on the paid up equity shares of the company, Apollo Hospitals said.


    Shares of Apollo Hospitals Enterprise were trading at Rs 1,204.90 per scrip on the BSE, up 0.13 per cent from its previous close.

    amortisationApolloApollo HospitalsApollo Hospitals EnterpriseApollo Hospitals net profitapollo share priceBSEconsolidateddepreciationEBITDAHealthcareIndiainterestnet profitNew DelhiPrathap C ReddyShares of Apollo HospitalsTax
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok